NXF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.634950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.926840E-01
Normal-vs-Stage2
1.633830E-01
Normal-vs-Stage3
1.823700E-02
Normal-vs-Stage4
1.356790E-01
Stage1-vs-Stage2
5.848800E-01
Stage1-vs-Stage3
1.205640E-02
Stage1-vs-Stage4
6.200200E-01
Stage2-vs-Stage3
3.144100E-02
Stage2-vs-Stage4
3.234000E-01
Stage3-vs-Stage4
4.147900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.651220E-01
Normal-vs-AfricanAmerican
4.054200E-02
Normal-vs-Asian
1.552990E-01
Caucasian-vs-AfricanAmerican
8.970800E-01
Caucasian-vs-Asian
6.282000E-01
AfricanAmerican-vs-Asian
8.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.611190E-01
Normal-vs-Female
1.676600E-01
Male-vs-Female
6.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.434980E-01
Normal-vs-Age(41-60Yrs)
1.861800E-01
Normal-vs-Age(61-80Yrs)
1.041740E-04
Normal-vs-Age(81-100Yrs)
1.637160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.649800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.796200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.356600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.294000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.240800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.597100E-04
Normal-vs-Daily Drinker
1.221260E-03
Normal-vs-Weekly Drinker
3.382700E-03
Normal-vs-Occasional Drinker
1.096050E-02
Normal-vs-Social Drinker
1.826010E-01
Non Drinker-vs-Daily Drinker
6.446800E-01
Non Drinker-vs-Weekly Drinker
6.914600E-01
Non Drinker-vs-Occasional Drinker
3.343600E-01
Non Drinker-vs-Social Drinker
3.171200E-01
Daily Drinker-vs-Weekly Drinker
9.959600E-01
Daily Drinker-vs-Occasional Drinker
5.801200E-01
Daily Drinker-vs-Social Drinker
5.595200E-01
Weekly Drinker-vs-Occasional Drinker
6.228600E-01
Weekly Drinker-vs-Social Drinker
5.731400E-01
Occasional Drinker-vs-Social Drinker
9.593600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.160000E-01
Normal-vs-Grade 2
8.637500E-02
Normal-vs-Grade 3
6.019800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.415800E-01
Grade 1-vs-Grade 3
7.779600E-01
Grade 1-vs-Grade 4
3.160000E-01
Grade 2-vs-Grade 3
5.021800E-01
Grade 2-vs-Grade 4
8.637500E-02
Grade 3-vs-Grade 4
6.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.509410E-01
Normal-vs-NonDiabetic
1.642170E-01
Diabetic-vs-NonDiabetic
3.764600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.011530E-02
Normal-vs-NoPancreatitis
1.567650E-01
Pancreatitis-vs-NoPancreatitis
2.915800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.959300E-04
Normal-vs-N1
1.619610E-01
N0-vs-N1
7.402400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.416980E-01
Normal-vs-TP53-NonMutant
3.097300E-03
TP53-Mutant-vs-TP53-NonMutant
1.564440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
